Back to ICD-10 codes
M75ICD-10-CM

Chapter 13 · M00–M99 · Musculoskeletal System

Shoulder lesions

M75 is the ICD10 code used for documenting Shoulder lesions in orthopedic, sports medicine, and rehabilitation care.

What M75 covers · when clinicians use it

ICD-10 code M75 identifies Shoulder lesions in the U.S. ICD-10-CM clinical and billing record set. It sits within the Musculoskeletal System chapter (M00–M99), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply M75 when an encounter's findings match the Shoulder lesions description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify M75 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for M75 and is a coding reference, not clinical, diagnostic, or billing advice.

M75 refers to Shoulder lesions, a broad category encompassing injuries, inflammations, and degenerative changes affecting muscles, tendons, bursae, and connective tissue due to repetitive strain, overuse, pressure, or idiopathic causes.

Symptoms

  • Localized pain and tenderness – Typical of bursopathies (M71), enthesopathies (M76, M77), and soft tissue overuse syndromes (M70)
  • Swelling or palpable nodules – Common in bursitis, fibromatosis (M72)
  • Reduced joint movement – Notable in shoulder lesions (M75) like rotator cuff tears
  • Stiffness and weakness – Across all soft tissue disorders
  • Crepitus during motion – Sometimes present in chronic soft tissue injuries

Diagnosis

Diagnosis of Shoulder lesions involves thorough physical examination, musculoskeletal ultrasound, MRI for soft tissue detail, and sometimes aspiration of bursae or biopsy (for fibroblastic lesions) to differentiate benign from aggressive conditions.

ICD10 Code Usage

ICD10 code M75 is used by orthopedic surgeons, sports medicine physicians, rheumatologists, physical therapists, and rehabilitation teams to document soft tissue disorders and guide treatment including rest, physical therapy, injections, or surgery.

Related Codes

FAQs

Q1: What is ICD10 code M75?
A: It refers to Shoulder lesions, covering a range of soft tissue injuries and disorders resulting from overuse, mechanical stress, or abnormal tissue proliferation.

Q2: What are bursopathies (M71)?
A: Disorders of the bursae (fluid-filled sacs), commonly presenting as bursitis due to friction, pressure, or trauma.

Q3: What are enthesopathies (M76, M77)?
A: Disorders where tendons or ligaments attach to bone, often leading to pain and inflammation (e.g., tennis elbow, jumper's knee).

Q4: What are fibroblastic disorders (M72)?
A: Conditions like Dupuytren's contracture, where fibroblast proliferation leads to abnormal thickening or scarring of connective tissue.

Q5: How are these conditions treated?
A: Treatment includes conservative management (rest, NSAIDs, physical therapy), corticosteroid injections, extracorporeal shockwave therapy, or surgical intervention if conservative measures fail.

Conclusion

ICD10 code M75 provides a standardized framework for diagnosing and treating Shoulder lesions, facilitating early intervention, improved mobility, and better long-term outcomes for patients with soft tissue injuries or disorders.

Source: ICD-10-CM (CMS / CDC NCHS official code set)

Last reviewed:

This page is a documentation reference for the ICD-10-CM code set and is not clinical, diagnostic, or billing advice. Always verify codes against the official ICD-10-CM source and your payer's guidelines.

Stop searching codes. Start delivering care.

Augustun captures the visit, drafts the note, and proposes ICD-10 codes with rationale — trusted by 10,000+ clinicians.